Ovarian Sertoli-Leydig cell tumours: How typical is their typical presentation?

被引:11
|
作者
Melero Cortes, Lidia Maria [1 ]
Martinez Maestre, M. Angeles [1 ]
Vieites Perez-Quintela, M. Begona [2 ]
Gambadauro, Pietro [3 ,4 ]
机构
[1] Virgen del Rocio Univ Hosp, Gynecol Div, C Manuel Siurot S-N, Seville, Spain
[2] Virgen del Rocio Univ Hosp, Pathol Dept, Seville, Spain
[3] Uppsala Univ Hosp, Ctr Reprod, Uppsala, Sweden
[4] Karolinska Inst, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden
关键词
Ovarian tumours; Sertoli-Leydig cell tumour; gynaecological endocrinology; hyperandrogenism; abnormal uterine bleeding; fertility preservation; OF-THE-LITERATURE; CLINICOPATHOLOGICAL ANALYSIS; MANAGEMENT;
D O I
10.1080/01443615.2017.1291590
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ovarian Sertoli-Leydig cell tumours (OSLCT) are rare and typically present with androgenic manifestations in women of the 2nd-3rd decade. Out of 228 diagnoses of ovarian sex cord-stromal tumours recorded at an academic institution during a 14-year period, eight women were surgically treated for OSLCT. Patient mean age was 54.8years (range 19-81), five women being in the postmenopausal stage (62.5%). Only one woman presented with androgenic manifestations (12.5%), four with abnormal/postmenopausal uterine bleeding (50%), and three with abdominal pain (37.5%). Fertility sparing or radical surgery was performed depending on patient age and stage of disease. The only patient with an advanced disease (FIGO stage IV) was referred to palliative care postoperatively. The other seven were at FIGO stage I. Five of them were free from disease at a mean follow-up of 67months, while the remaining two were lost at follow-up. The youngest woman of the series, treated with fertility-preserving unilateral salpingo-oophorectomy at the age of 19, had two spontaneous pregnancies and deliveries of healthy babies during a 10-year follow-up period. In conclusion, our single institution 14-year experience demonstrates that the diagnosis of OSLCT is particularly challenging since many patients are older than expected and lack androgenic manifestations. Impact statement center dot What is already known on this subjectOvarian Sertoli-Leydig cell tumours (OSLCT) are rare and are thought to typically present with androgenic manifestations in women of the 2nd-3rd decade.center dot What the results of this study addOur single institution 14-year experience shows that a high proportion of women with ovarian Sertoli-Leydig cell tumours may not present with androgenic manifestations, and many of them also are in the postmenopausal stage. Most patients have a good prognosis and fertility-preserving surgery in younger women can lead to spontaneous pregnancies and deliveries of healthy children after treatment.center dot What are the implications of these findings for clinical practice and/or further researchThe diagnosis of OSLCT is particularly challenging and therefore not reached before surgery in most of the cases. However, while hysterectomy with bilateral salpingo-oophorectomy and surgical staging are recommended for women with higher stage or no fertility wish, fertility-sparing surgery should be considered in younger women with early disease. Therefore, further research should focus on non-invasive diagnosis possibly by means of laboratory or imaging techniques.
引用
收藏
页码:655 / 659
页数:5
相关论文
共 50 条
  • [1] Ovarian Sertoli-Leydig cell tumours: A systematic review of relapsed cases
    Nef, James
    Huber, Daniela Emanuela
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2021, 263 : 261 - 274
  • [2] Review on Sertoli-Leydig Cell Tumours of the Ovary
    Muscat, Corinne
    Calleja-Agius, Jean
    DISCOVERY MEDICINE, 2024, 36 (181) : 234 - 247
  • [3] Mucinous elements in Sertoli-Leydig and granulosa cell tumours: A revaluation
    DoussisAnagnostopoulou, IA
    Remadi, S
    Czernobilsky, B
    HISTOPATHOLOGY, 1996, 28 (04) : 372 - 375
  • [4] Ovarian Sertoli-Leydig cell tumors. A retrospective MITO study
    Sigismondi, Cristina
    Gadducci, Angiolo
    Lorusso, Domenica
    Candiani, Massimo
    Breda, Enrico
    Raspagliesi, Francesco
    Cormio, Gennaro
    Marinaccio, Marco
    Mangili, Giorgia
    GYNECOLOGIC ONCOLOGY, 2012, 125 (03) : 673 - 676
  • [5] Ovarian Sertoli-Leydig Cell Tumors: Epidemiological, Clinical and Prognostic Factors
    Ruiz Castro, Beatriz Guerreiro
    Souza, Cristiano de Padua
    Mattos da Cunha Andrade, Carlos Eduardo
    Vieira, Marcelo de Andrade
    Pinto de Andrade, Diocesio Alves
    dos Reis, Ricardo
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2019, 41 (07): : 440 - 448
  • [6] Ovarian Sertoli-Leydig cell tumors: an analysis of 13 cases
    Guo, Ying
    Wang, Jing
    Li, Yuhong
    Wang, Yudong
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 302 (01) : 203 - 208
  • [7] Ovarian Sertoli-Leydig cell tumors: a single institution experience and review of the literature
    Gressel, G. M.
    Buza, N.
    Pal, L.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (02) : 214 - 220
  • [8] Ovarian Sertoli-Leydig tumor: A tricky tumor
    Brandone, Nicolas
    Borrione, Claude
    Rome, Angelique
    de Paula, Andre Maues
    ANNALES DE PATHOLOGIE, 2018, 38 (02) : 131 - 136
  • [9] Ovarian Sertoli-Leydig cell tumors: MRI findings and pathological correlation
    Cai, Song-Qi
    Zhao, Shu-Hui
    Qiang, Jin-Wei
    Zhang, Guo-Fu
    Wang, Xue-Zhen
    Wang, Li
    JOURNAL OF OVARIAN RESEARCH, 2013, 6
  • [10] Ovarian Sertoli-Leydig cell tumour with rhabdomyosarcoma and borderline mucinous neoplasm
    Chougule, Abhijit
    Singh, Priya
    Saha, Pradip Kumar
    Dey, Pranab
    PATHOLOGY, 2016, 48 (03) : 278 - 281